|
Volumn 8, Issue 9, 2002, Pages 2963-2969
|
Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTOCHROME C;
MEBENDAZOLE;
ANGIOGENESIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CANCER CELL;
CANCER INHIBITION;
CELL CYCLE;
CONTROLLED STUDY;
DOSE TIME EFFECT RELATION;
ENDOTHELIUM CELL;
ENZYME RELEASE;
FLUORESCENCE ACTIVATED CELL SORTING;
HUMAN;
HUMAN CELL;
LUNG CANCER;
MOUSE;
MOUSE STRAIN;
NONHUMAN;
PRIORITY JOURNAL;
UMBILICAL VEIN;
XENOGRAFT;
ANIMALS;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
CARCINOMA, NON-SMALL-CELL LUNG;
CELL DIVISION;
CELL LINE;
ENDOTHELIUM, VASCULAR;
FEMALE;
FIBROBLASTS;
G2 PHASE;
HUMANS;
LUNG NEOPLASMS;
MEBENDAZOLE;
MICE;
MICE, INBRED C3H;
MICE, NUDE;
NEOVASCULARIZATION, PATHOLOGIC;
RADIATION CHIMERA;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 0036716849
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (159)
|
References (30)
|